Vesedaganat: vizsgálatok itt: Franciaország
57 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Angers, Dijon, Le Mans, Marseille, Nice Cedex 2, Paris, Saint-Priest-en-Jarez, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - 3. fázisTaking peopleA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Where
- Angers, Bayonne, Bordeaux Cedex, Creteil Cedex, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Limoges Cedex I, Montpellier, Nancy, Pierre-Bénite, Rouen, Suresnes
- Életkor
- 18 év and over
- People
- 904 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Angers, Limoges Cedex I, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - 3. fázisTaking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Angers, Bordeaux Cedex, Brest, Caen Cedex 5, Clermont Ferrand Cedex1, Lille, Marseille, Montpellier Cedex 5, Paris, Poitiers, Reims, Rennes Cedex, Saint-Herblain Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - 1/2. fázisTaking peopleSubstudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Where
- Rennes Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandouvre Les Nancy, Villejuif
- Életkor
- 18 év to 120 év
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07049926 · EU 2024-516437-12-00 - 1/2. fázisNot yet taking people in FranciaországA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Bordeaux Cedex, Lille, Villejuif
- Életkor
- 18 év and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - 1. fázisTaking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Lyon, Paris, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - No phaseTaking peoplePost-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy
- Where
- Marseille
- Életkor
- 18 év and over
- People
- 60
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT06882486 - No phaseTaking peopleBenchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
- Where
- Boulogne-Billancourt, Paris
- Életkor
- 18 év and over
- People
- 100
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07739121 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Besancon Cedex, Bordeaux, Caen Cedex 5, Clermont Ferrand Cedex1, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain, Strasbourg Cedex 2, Vandoeuvre Les Nancy_ Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 1/2. fázisTaking peopleStudy of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Where
- Villejuif
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Oncorena AB
See details and how to joinNCT05287945 - 1. fázisNot yet taking people in FranciaországA Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Marseille, Villejuif
- Életkor
- 18 év and over
- People
- 112 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295 - 3. fázisTaking peopleCARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
- Where
- 71100, Ajaccio, Angers, Avignon, Bayonne, Besançon, Bordeaux Cedex, Boujan-sur-Libron, Boulogne-sur-Mer, Brest, Caen Cedex 5, Chalon Sur Saone Cedex, Chambéry, Clermont-Ferrand, Colmar Cedex, Compiègne, Creteil Cedex, Dax, Dijon, Epagny Metz-Tessy, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Lille, Limoges Cedex 1, Limoges Cedex I, Lyon, Marseille, Martinique, Mont-De-Marsan Cedex, Montpellier Cedex 5, Nice Cedex 2, Nimes Cedex 9, ORLEANS, Paris, Paris Cedex 20, Pau Cedex, Pierre-Bénite, Plérin, Poitiers, Reims, Rennes Cedex, Saint-Denis, Saint-Etienne, Saint-Mande, Saint-Priest-en-Jarez, St Herblain, St Nazaire, Strasbourg, Suresnes, Toulouse, Tours Cedex 9, Vandouvre Les Nancy, Villefranche-sur-Saône, Villejuif
- Életkor
- 18 év and over
- People
- 1373 worldwide
- Run by
- Institut Gustave Roussy
See details and how to join2023-503317-29-00 - 1. fázisNot yet taking people in FranciaországPhase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma
- Where
- Lyon
- Életkor
- 18 év and over
- People
- 26
- Run by
- Centre Leon Berard
See details and how to joinNCT07828249 · EU 2026-525526-38-00 - 1/2. fázisTaking peopleKidney cancer
- Where
- Villejuif
- Életkor
- 18 év and over
- People
- 105 worldwide
- Run by
- Oncorena AB
See details and how to join2023-505605-16-00 - No phaseTaking peopleDevelopment of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)
- Where
- Strasbourg
- Életkor
- 18 év and over
- People
- 100
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07820566 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Besançon, Levallois-Perret, Marseille, Neuilly, Paris
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - 4. fázisNot yet taking people in FranciaországRandomized study evaluating the impact of an innovative and cooperative pathway integrating oncogeriatric, pharmaceutical and pharmacological follow-up in elderly patients (>70 years old) presenting with cancer and treated with oral therapy_POG
- Where
- Bron, Caluire-et-Cuire, Chevilly-Larue, Dijon, Lille Cedex, Lyon Cedex 04, Marseille, Paris, PARIS, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Cloud, Strasbourg Cedex 2, Toulouse, Villejuif
- Életkor
- 65 év and over
- People
- 794
- Run by
- Institut Gustave Roussy
See details and how to join2025-523610-83-00 - 4. fázisNot yet taking people in FranciaországInnovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.
- Where
- Villejuif
- Életkor
- 70 év and over
- People
- 794
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07802847 - No phaseNot yet taking people in FranciaországRegistry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
- Where
- Créteil, Lyon
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Mark C Burgmans, MD PhD
See details and how to joinNCT07636148 - 1/2. fázisTaking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Clermont Ferrand Cedex1, Dijon, La Tronche, Lyon, Marseille, Nantes, Pessac, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - 1. fázisTaking peopleA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Bordeaux Cedex, Marseille, Villejuif
- Életkor
- 18 év and over
- People
- 281 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07195682 · EU 2025-522543-18-00 - No phaseTaking peopleIdentification and Description of Patients With High-risk Non Metastatic RCC
- Where
- Bordeaux
- Életkor
- 18 év and over
- People
- 6109
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07753343 - 1. fázisTaking peopleStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Bordeaux, Villejuif
- Életkor
- 18 év and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00 - 4. fázisTaking peopleDigital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
- Where
- Avignon, Bayeux, Boulogne-sur-Mer, Caen, Caen Cedex 5, Coudekerque-Branche, Creil, Dijon, Epagny Metz-tessy, Lorient, Lyon, Montpellier Cedex 5, Mulhouse, Nice Cedex 2, Poitiers, St Etienne Cedex 2, Suresnes, Tours, Vannes
- Életkor
- 18 év and over
- People
- 83
- Run by
- Centre Francois Baclesse
See details and how to joinNCT07028125 · EU 2024-518991-30-00